Consumer Product Recall: Mamisan Pain Relieving Topical Ointment
MiramarLab, of Doral, Florida · December 18, 2025
Reason for Recall
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Product Description
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
Quantity Affected
About 50,330
Source: Consumer Product Safety Commission
Recall number: 26157
Status: ongoing
View original recall notice at Consumer Product Safety Commission →
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.